Peter Tontonoz
Anatomic Pathology · Los Angeles, CANPI 1003845785
Payments from drug & device makers
What this record shows
This record is dominated by other: $13,626,338 of the $13,634,158 with a category attached, or 99.9%. Pfizer accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2021 is the largest year on record at $13,632,628, more than ten times the $51 reported in 2019. Among anatomic pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 5 payments — averaging $2,726,832 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$13.6M
- Merck$51
What the payments were for
- Speaking & faculty fees$7,7700%
- Food & beverage$510%
- Other$13,626,338100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$13,634,158 in reported general payments places this provider in the 95th percentile of 154 anatomic pathology providers in California.
Other anatomic pathology in Los Angeles
- Sheeja PullarkatLos Angeles$253K
- Anthony SiskLos Angeles$79K
- Michael PressLos Angeles$76K
- Dinesh RaoLos Angeles$54K
- Jonathan ZuckermanLos Angeles$24K
- Hanlin WangLos Angeles$20K
- Jianyu RaoLos Angeles$7K
- Jonathan SaidLos Angeles$6K
- Louis DubeauLos Angeles$3K
- Farres ObeidinLos Angeles$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.